Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06230861
NA

Effects of Quercetin on Cardiometabolic Outcomes

Sponsor: University of Central Lancashire

View on ClinicalTrials.gov

Summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Quercetin may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

Official title: Effects of Quercetin Supplementation on Cardiometabolic Parameters

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2024-03-01

Completion Date

2026-12-01

Last Updated

2026-02-27

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Quercetin

Quercetin tablets 500mg 1 x per day

OTHER

Placebo

Placebo control 1 x blinded placebo tablet per day

Locations (1)

University of Central Lancashire

Preston, Lancashire, United Kingdom